ReviewBMC pulmonary medicine2024

Immune checkpoint inhibitor-related pneumonitis following discontinuation of pembrolizumab in a patient with advanced lung adenocarcinoma: a case report and literature review.

Huan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.